Amy Elaine Litwiller, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4600 Frontage Rd, Hillside, IL 60162 Phone: 708-544-9933 |
Erin Marie Brophy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4600 Frontage Rd, Hillside, IL 60162 Phone: 708-544-9933 |
Mrs. Jennifer Davies, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1815 S Wolf Rd, Hillside, IL 60162 Phone: 708-236-0979 |
Emily L Vokac, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1815 S Wolf Rd, Hillside, IL 60162 Phone: 708-236-0979 Fax: 708-236-5161 |
Ms. Diana Marie Daniak, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 323 Oak Ridge Ave, Hillside, IL 60162 Phone: 708-547-6595 |
Kelly Anne Newhouse, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1815 S Wolf Rd, Hillside, IL 60162 Phone: 708-236-0979 |
Marni Garfinkel, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1815 S Wolf Rd, Hillside, IL 60162 Phone: 708-236-0979 |
Louisa Susan Mahoney, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4600 Frontage Rd, Hillside, IL 60162 Phone: 708-544-9933 Fax: 708-544-9966 |
News Archive
A primary care nurse-delivered intervention can lead to sustained increases in physical activity (PA) among older adults, according to an article published by Tess Harris of St George's University of London, and colleagues in this week's PLOS Medicine. The trial was funded by the National Institute for Health Research.
The European Respiratory Society has launched a new multilingual website specifically targeted at patients with chronic bronchitis, emphysema or other "chronic obstructive pulmonary disease" (COPD), group of conditions in which the patient has an expiratory airflow obstruction that causes air to become trapped in the lung and limit the ability to exhale.
The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in women with hormone-sensitive breast cancer. But it works better in some women than others. Researchers are not sure why.
Mylan Inc. today announced its financial results for the three months ended March 31, 2011.
› Verified 1 days ago